Inactive Instrument

Press Releases Flamel Technologies S.A. (ADR) Nasdaq

Equities

US3384881096

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 25	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	MT
Apr. 23	European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference	Apr. 01	AQ
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences	Mar. 05	AQ
Avadel Pharmaceuticals Issues Statement On Patent Litigation	Mar. 04	AQ
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results	Mar. 04	AQ
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4	Feb. 26	AQ
Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 07	AQ
Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial Highlights	Jan. 08	AQ
Avadel: Q3 Earnings Snapshot	Nov. 08	AQ
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results	Nov. 08	AQ
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences	Nov. 07	AQ
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 8	23-10-30	AQ
Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ for extended-release oral suspension at World Sleep 2023	23-10-23	AQ
Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ (sodium oxybate) for extended-release oral suspension (CIII) at World Sleep 2023	23-10-20	AQ
Avadel Pharmaceuticals to Present at the Jefferies Biotech CNS/Neuro Summit	23-10-05	AQ
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences	23-08-31	AQ
Avadel: Q2 Earnings Snapshot	23-08-09	AQ
Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results	23-08-09	AQ
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	23-08-03	AQ
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9	23-08-02	AQ
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	23-07-20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Flamel Technologies S.A. (ADR) Nasdaq

Equities

US3384881096

Press Releases

Filters